ZURICH (Thomson Financial) - Lonza Group AG said it plans to continue its expansion into advanced technologies with a new plant for highly potent active pharmaceutical ingredients (API), investing some 80 mln sfr in the construction of API capacity.
ZURICH (Thomson Financial) - Lonza Group AG said it plans to continue its expansion into advanced technologies with a new plant for highly potent active pharmaceutical ingredients (API), investing some 80 mln sfr in the construction of API capacity.
